PortfoliosLab logoPortfoliosLab logo
LUNA vs. KRMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LUNA vs. KRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LUNA achieves a 8.70% return, which is significantly higher than KRMD's -29.26% return. Over the past 10 years, LUNA has underperformed KRMD with an annualized return of -0.77%, while KRMD has yielded a comparatively higher 23.80% annualized return.


LUNA

1D
0.81%
1M
0.81%
6M
-13.19%
YTD
8.70%
1Y
25.00%
3Y*
-47.98%
5Y*
-36.73%
10Y*
-0.77%
ALL TIME*
-7.49%

KRMD

1D
0.00%
1M
-8.46%
6M
-23.75%
YTD
-29.26%
1Y
18.10%
3Y*
17.32%
5Y*
3.80%
10Y*
23.80%
ALL TIME*
11.77%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$645.21K$536.52K$587.45K
$19.98K$41.16K$64.40K

LUNA vs. KRMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LUNA
Luna Innovations Incorporated
8.70%-46.76%-67.52%-24.35%4.15%-14.57%35.53%117.61%37.86%65.31%
KRMD
Repro Med Systems, Inc.
-29.26%50.91%56.82%-31.23%19.00%-50.17%-7.81%295.76%32.00%150.00%

Correlation

The correlation between LUNA and KRMD is -0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.05

Correlation (3Y)
Balances recent behavior with more history.

0.09

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.12

Correlation (10Y)
Provides a long-term view across more market conditions.

0.10

Correlation (All Time)
Calculated using the full available price history since Jun 5, 2006

0.07

The correlation between LUNA and KRMD shifts across timeframes, from -0.05 (1 year) to 0.12 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LUNA:

$43.37M

KRMD:

$188.78M

Total Revenue (TTM)

LUNA:

$116.61M

KRMD:

$43.26M

Gross Profit (TTM)

LUNA:

$68.80M

KRMD:

$25.98M

EBITDA (TTM)

LUNA:

$7.02M

KRMD:

-$1.51M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Luna Innovations Incorporated

Repro Med Systems, Inc.

Return for Risk

LUNA vs. KRMD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LUNA
LUNA Risk / Return Rank: 6161
Overall Rank
LUNA Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
LUNA Sortino Ratio Rank: 6565
Sortino Ratio Rank
LUNA Omega Ratio Rank: 7575
Omega Ratio Rank
LUNA Calmar Ratio Rank: 5858
Calmar Ratio Rank
LUNA Martin Ratio Rank: 5656
Martin Ratio Rank

KRMD
KRMD Risk / Return Rank: 5656
Overall Rank
KRMD Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
KRMD Sortino Ratio Rank: 5959
Sortino Ratio Rank
KRMD Omega Ratio Rank: 5555
Omega Ratio Rank
KRMD Calmar Ratio Rank: 5656
Calmar Ratio Rank
KRMD Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LUNA vs. KRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LUNAKRMDDifference
Sharpe ratioReturn per unit of total volatility

-0.18

Sortino ratioReturn per unit of downside risk

+0.23

Omega ratioGain probability vs. loss probability

1.22

1.11

+0.12

Calmar ratioReturn relative to maximum drawdown

0.50

0.44

+0.06

Martin ratioReturn relative to average drawdown

0.98

0.75

+0.23

LUNA vs. KRMD - Sharpe Ratio Comparison

The current LUNA Sharpe Ratio is 0.19, which is lower than the KRMD Sharpe Ratio of 0.37. The chart below compares the historical Sharpe Ratios of LUNA and KRMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LUNA vs. KRMD - Drawdown Comparison

The maximum LUNA drawdown since its inception was -97.65%, roughly equal to the maximum KRMD drawdown of -97.69%. Use the drawdown chart below to compare losses from any high point for LUNA and KRMD.


Loading charts...

Drawdown Indicators


LUNAKRMDDifference

Max Drawdown

Largest peak-to-trough decline

-97.65%

-97.69%

+0.04%

Max Drawdown (1Y)

Largest decline over 1 year

-50.29%

-42.79%

-7.50%

Max Drawdown (3Y)

Largest decline over 3 years

-96.66%

-57.96%

-38.70%

Max Drawdown (5Y)

Largest decline over 5 years

-97.65%

-57.96%

-39.69%

Max Drawdown (10Y)

Largest decline over 10 years

-97.65%

-84.30%

-13.35%

Current Drawdown

Current decline from peak

-90.23%

-66.91%

-23.32%

Average Drawdown

Average peak-to-trough decline

-65.40%

-59.17%

-6.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.66%

25.10%

+0.56%

Volatility

LUNA vs. KRMD - Volatility Comparison

The current volatility for Luna Innovations Incorporated (LUNA) is 4.30%, while Repro Med Systems, Inc. (KRMD) has a volatility of 12.11%. This indicates that LUNA experiences smaller price fluctuations and is considered to be less risky than KRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LUNAKRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.30%

12.11%

-7.81%

Volatility (6M)

Calculated over the trailing 6-month period

59.14%

32.60%

+26.54%

Volatility (1Y)

Calculated over the trailing 1-year period

132.05%

51.23%

+80.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

109.08%

59.85%

+49.23%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.26%

68.44%

+17.82%

Dividends

LUNA vs. KRMD - Dividend Comparison

Neither LUNA nor KRMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LUNA vs. KRMD - Financials Comparison

This section allows you to compare key financial metrics between Luna Innovations Incorporated and Repro Med Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


LUNA and KRMD have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KRMD has higher volatility (12.11%) compared to LUNA (4.30%). In terms of maximum drawdown, LUNA dropped -97.65% vs KRMD's -97.69%.

KRMD currently has the higher Sharpe Ratio (0.37 vs 0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LUNA and KRMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer